HAPILA GmbH - Business Segments
HAPILA is engaged in three major business areas of the API value-creation chain: synthesis, purification and particle design; this makes HAPILA a highly efficient bridge-builder between production of the API and its suitability for pharmaceutical production.
We offer services:
- to develop chemical-pharmaceutical syntheses of active ingredients including development of analytical methods;
- to manufacture reference standard substances which are complicated to synthesise;
- to develop purification procedures for pharmaceutical ingredients using our patented HAPIpur®-Technology (fully automated continuous counter current flow multi-stage crystallisation);
- to develop design processes (particle design / particle engineering) for pharmaceutical ingredients for specific pharmaceutical applications;
- for scale-up and GMP manufacturing for synthesis, purification and particle design;
- to prepare necessary supporting regulatory documentation – i.e. DMF (3.2.S-part… for API), ASMF, IMPD, CEP and
- in general for handling pharmaceutical ingredients.